ACI Releases Paper on the Effects of Adopting Foreign Price Controls on Drugs Byeditor June 19, 2019June 19, 2019
Regulatory Uncertainty and Industry Practices Force Consumers to Overpay on Biologics ByAlan Daley February 19, 2019
Making the Case for Biosimilars: ACI in the Hill’s Congressional Blog ByProf. Joseph Fuhr July 30, 2014July 30, 2014
